IP Library Patent Application 17163810
Patent Application
App. No. 17/163,810

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/163,810
Abstract

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

Claims (9)

1 .- 15 . (canceled)

16 . A method of lowering LDL cholesterol in a human, comprising administering orally to a human in need of such treatment a therapeutically effective amount of a compound represented by:

17 . The method of claim 16 , wherein the compound is administered orally to the human in the form of a pharmaceutical composition comprising the compound, and a pharmaceutically acceptable vehicle.

18 . The method of claim 16 , wherein the human has familial hypercholesterolemia.

19 . The method of claim 16 , wherein the human has cardiovascular disease.

20 . The method of claim 19 , wherein the cardiovascular disease is atherosclerotic cardiovascular disease.

21 . The method of claim 17 , wherein the human has familial hypercholesterolemia.

22 . The method of claim 17 , wherein the human has cardiovascular disease.

23 . The method of claim 22 , wherein the cardiovascular disease is atherosclerotic cardiovascular disease.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →
SECURITY INTEREST Recorded Apr 26, 2021
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 056044/0988 →